Bookmark and Share

Industry Reports >> Medical Devices

 
Single User license
$3,995.00
Site license
$7,990.00
Global license
$11,985.00
 
  • Description
  • Table of Contents
  • List of Figures
  • List of Tables
  • Request Sample Pages
  • Send to a Friend
  • Inquire Before Buying

Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

By: GlobalData, Published: Jan-2012    Report Code: GDME0129MAR

Description

GlobalData’s new report, “Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global blood glucose monitoring devices market. The report provides market landscape, competitive landscape and market trends information on the blood glucose monitoring devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

  • - Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • - Key segments covered include Blood Glucose Meters, Blood Glucose Test Strips and Lancets.
  • - Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
  • - Qualitative analysis of key market trends, market drivers, and restraints within the blood glucose monitoring devices market.
  • - The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • - Key players covered include F. Hoffmann-La Roche Ltd, LifeScan, Inc., Bayer HealthCare AG and Abbott Laboratories.



Reasons to Buy

  • - Develop business strategies by understanding the trends and developments that are driving the blood glucose monitoring devices globally.
  • - Design and develop your product development, marketing and sales strategies.
  • - Develop market-entry and market expansion strategies.
  • - Identify key players best positioned to take advantage of the emerging market opportunities.
  • - Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • - What’s the next big thing in the blood glucose monitoring devices market landscape? – Identify, understand and capitalize.
  • - Make more informed business decisions from the insightful and in-depth analysis of the global blood glucose monitoring devices market and the factors shaping it.

Sagepay